Status:
COMPLETED
Dialectical Behavior Therapy for Adults With Autism Spectrum Disorders
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Autism Spectrum Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dialectical Behavior Therapy (DBT; Linehan, 1993) effectively diminishes emotion dysregulation and self-harm behaviors in a number of disorders. However, to our knowledge, no studies have investigated...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- ASD diagnosis according to the DSM-5
- IQ ≥ 70
- Suicidal ideas, suicidal attempts and/or self-harm behaviors 6 months prior to the inclusion
- Able to understand and consent to the research aims
- Membership in a health insurance fund
Exclusion
- complete hospitalization
- ongoing CBT or DBT
- past DBT
- schizophrenia disorders
- under guardianship
Key Trial Info
Start Date :
April 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04737707
Start Date
April 16 2021
End Date
June 1 2025
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de psychiatrie
Strasbourg, France, 67000